Analysis of the key themes driving M&A activity reveals that social responsibility accounted for 6 pharmaceutical deals announced in Q2 2023, worth a total value of $13m. The $13m minority acquisition of Mylab Discovery Solutions by Zydus Animal Health And Investments was the industry’s largest disclosed deal. GlobalData’s Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes report for Q2 2023 dissects the driving forces behind the M&A dynamics within the Pharma sector, offering essential insights into industry trends and transformations. Buy the report here.
For further understanding of GlobalData's Pharmaceuticals Industry M&A Deals by Top Themes in Q2 2023 – Thematic Intelligence, buy the report here.